Sudden Cardiac Death Risk Assessment

作者: Katy E. Bockstall , Michael P. Gannon , Weijia Wang , Mark S. Link

DOI: 10.1007/978-1-4471-4956-9_10

关键词: Syncope (genus)Internal medicineMassive hypertrophyMedicineRisk assessmentSudden cardiac deathVentricular tachycardiaBlood pressureHypertrophic cardiomyopathyFamily historyCardiology

摘要: Sudden cardiac death is a major issue in patients with HCM. The young are at particular risk for SCD, while those over 60 less affected by SCD. There five traditional factors sudden HCM, including: massively thick myocardium, unexplained syncope, family history of SCD due to nonsustained ventricular tachycardia, and hypotensive response exercise. Currently, an ICD recommended resuscitated and/or sustained reasonable massive hypertrophy (>3 cm), syncope also NSVT or abnormal blood pressure exercise, but usually when combined other markers heightened risk.

参考文章(90)
Barry J. Maron, Win-Kuang Shen, Mark S. Link, Andrew E. Epstein, Adrian K. Almquist, James P. Daubert, Gust H. Bardy, Stefano Favale, Robert F. Rea, Giuseppe Boriani, N.A. Mark Estes, Paolo Spirito, Susan A. Casey, Marshall S. Stanton, Sandro Betocchi, Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy New England Journal of Medicine. ,vol. 342, pp. 365- 373 ,(2000) , 10.1056/NEJM200002103420601
Bernard J. Gersh, Barry J. Maron, Robert O. Bonow, Joseph A. Dearani, Michael A. Fifer, Mark S. Link, Srihari S. Naidu, Rick A. Nishimura, Steve R. Ommen, Harry Rakowski, Christine E. Seidman, Jeffrey A. Towbin, James E. Udelson, Clyde W. Yancy, 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy Journal of the American College of Cardiology. ,vol. 58, pp. e212- e260 ,(2011) , 10.1016/J.JACC.2011.06.011
Zhen Weng, Jialu Yao, Raymond H. Chan, Jun He, Xiangjun Yang, Yafeng Zhou, Yang He, Prognostic Value of LGE-CMR in HCM JACC: Cardiovascular Imaging. ,vol. 9, pp. 1392- 1402 ,(2016) , 10.1016/J.JCMG.2016.02.031
Ferdinando Pasquale, Petros Syrris, Juan Pablo Kaski, Jens Mogensen, William J. McKenna, Perry Elliott, Long-Term Outcomes in Hypertrophic Cardiomyopathy Caused by Mutations in the Cardiac Troponin T Gene Circulation-cardiovascular Genetics. ,vol. 5, pp. 10- 17 ,(2012) , 10.1161/CIRCGENETICS.111.959973
Ethan J Rowin, Martin S Maron, , , The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy. Arrhythmia and Electrophysiology Review. ,vol. 5, pp. 197- 202 ,(2016) , 10.15420/AER.2016:13:3
Amar Trivedi, Bradley P Knight, , , ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy. Arrhythmia and Electrophysiology Review. ,vol. 5, pp. 188- 196 ,(2016) , 10.15420/AER.2016:30:2
Bernard J. Gersh, Barry J. Maron, Robert O. Bonow, Joseph A. Dearani, Michael A. Fifer, Mark S. Link, Srihari S. Naidu, Rick A. Nishimura, Steve R. Ommen, Harry Rakowski, Christine E. Seidman, Jeffrey A. Towbin, James E. Udelson, Clyde W. Yancy, 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation. ,vol. 124, pp. 2761- 2796 ,(2011) , 10.1161/CIR.0B013E318223E230
, Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney, ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities Circulation. ,vol. 117, ,(2008) , 10.1161/CIRCUALTIONAHA.108.189742